Richard Vlasimsky - Finding Lung Cancer Early

Angel Scale Biotech: Learn More

Richard Vlasimsky is using AI to create a low-cost way of vastly expanding our ability to detect lung cancer early. His algorithm for detecting lung nodules in chest x-rays just got FDA clearance. Listen to this remarkable founder who’s done a lot with modest funding.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

Sal Daher Introduces Richard Vlasimsky What IMIDEX is Solving "... how much your studies cost to get your 510k.." "... We had multiple radiologists looking at the image, and then we had a final truther that adjudicated these independent reads that the radiologist did..." "... Payers care about catching it early so that they have better outcomes and the costs are much lower ... The providers, being the medical systems or the physicians, typically hospitals, they care about it because of liability issues and also because they could have the opportunity to treat something and they would get the revenue stream..." "... It's like a very fine-tooth comb picks up all the nits. The specificity relates to how many of those things that you pick up are actually what you're looking for and not false positives..." Exit Possibilities "... his definition of a startup is an enterprise that uses resources that it does not yet command..." Richard’s Entrepreneurial Journey "... You had this experience of joining a startup, then creating your own startup which was using machine learning..." Advice to the Audience

Topics: biotech, discovering entrepreneurship, robotics/AI, founding story

In the Decade of Biotech when there will be myriad opportunities to invest in angel-scale biotech startups. After decades of angel investing, I am focusing on the life science side of my portfolio and invite other angels to do the same. Here's why: https://www.labcoatventures.com/why-we-are-focused-on-early-stage-biotech/

I’m Sal Daher, host of the Angel Invest Boston Podcast. After immigrating to Boston as a child and attending Belmont High School, I studied engineering at MIT and Stanford. Decades of work in international finance followed. During that time, I invested in a handful of ventures founded by friends and acquaintances. Now, I’m a member of Walnut Ventures and MIT Angels and spend most of my time as an angel investor. Startups in my portfolio include: SQZ Biotech, Gelesis, Akili Interactive, Vedanta Biosciences, FineTune Learning, Concrete Sensors, Squadle, doDoc, Pixability, Mavrck, Viral Gains, Streamroot, XMOS, Alice's Table and others. Exits include: Exos (Microsoft), Rifiniti (KKR) and PIKA Energy (Generac).

• No. of episodes: 309
• Latest episode: 2023-12-29
• Business Careers Entrepreneurship

Where can you listen?